Agalliu, I and Wang, Z (2013) Characteriztion of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. PLoS One, 8, e60083.
Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. British Journal of Cancer, 83(10): 1301–1308.
Blumen, H, Fitch, K and Polkus, V (2016) Comparison of treatment costs for breast cancer by tumor stage and type of service. American Health and Drug Benefits, 9(1): 23–31.
Chen, S and Parmigiani, G (2007) Meta-analysis of BRCA-1 and BRCA-2 penetrance. J Clin Oncol, 25(11): 1329–1333.
Classen, L and Henneman, L (2010) Using family history information to promote healthy lifestyles and prevent diseases: a discussion of the evidence. BMC Public Health, 10, 248.
Grosse, S (2015) When is genomic testing cost-effective? Testing for Lynch syndrome in patients with newly-diagnosed colorectal cancer and their relatives. Healthcare (Basel), 3(4):860–878.
Grosse, S, Palomaki, G, Myundura, M and Hampel, H (2015) The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates. Genetics in Medicine, 17(6): 510–511.
Heald, B, Endelman, E and Eng, C (2012) Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. European Journal of Human Genetics, 20, 547–551.
King, M, Levy-Lahad, E and Lahad, A (2014) Population based screening for BRCA1 and BRCA2: 2014 Lasker award. JAMA, 312(11): 1091–1092.
Klitzman, R and Chung, W (2010) The process of deciding about prophylactic surgery for breast and ovarian cancer: patient questions, uncertainties, communication. American Journal of Medical Genetics, 152A(1): 52–66.
Kuchenbaecker, K, Hopper, J and Barnes, D, et al. (2017) Risk of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23): 2402–2416.
Lerman, C, Hughes, C, Croyle, RT, Main, D, Durham, C, Snyder, C, Bonney, A, Lynch, JF, Narod, SA and Lynch, HT (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA 1/2 testing. Preventive Medicine, 31, 75–80.
Louis, L, Christophe, S and Cooper, A (2017) Long-term survival and cost of treatment in patients with Stage IIIC Epithelial Ovarian Cancer. Current Women’s Health Reviews, 13(2): 44–50.
May, T, Lee, R and Evans, J (2018) Editors’ introduction: health challenges faced by adopted persons lacking family health history information. Narrative Inquiry in Bioethics, 18(2): 103–106.
May, T and Strong, K (2016a) Does lack of genetic relative family health history represent a potentially avoidable health disparity for adoptees? American Journal of Bioethics, 16(12): 33–38.
May, T and Evans, J (2016b) Issues of ‘cost, capabilities and scope’ in characterizing adoptees’ lack of genetic relative family health history as an avoidable health disparity. American Journal of Bioethics, 16(12): W4–W8.
May, T, Strong, K, Khoury, M and Evans, J (2015) Can targeted genetic testing offer usful health information to adoptees? Genetics in Medicine, 17(7): 533–535.
Meijers-Heijboer, EJ, Verhoog, LC, Brekelmans, CTM, Seynaeve, C, Tilanus-Linthorst, MMA, Wagner, A, Dukel, L, Devilee, P, van den Ouweland, AMW, van Geel, AN and Klijn, JGM (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA 1 or BRCA2 mutation. Lancet, 355, 2015–2020.
Moyer, V, on behalf of the U.S. Preventive Services Task Force (USPSTF) (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. Annals of Internal Medicine, 160(4): 271–282.
Myundra, M, Grosse, S, Hampel, H and Palomaki, G (2010) The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med, 12(2): 93–104.
Siu, A, on behalf of the U.S. Preventive Services Task Force (2016) Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164(4): 279–296.
Smith, M and Hochhalter, A (2011) Utilization of screening mammography among middle-aged and older women. Journal of Women’s Health, 20(11): 1619–1626.
Quinn, G and Vadaparampil, S (2016) Begging the question: the fallacy of adoptees as a health disparity. American Journal of Bioethics, 16(12): 47–48.
Warner, E, Plewes, D and Hill, K (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mommography, and clinical breast examination. JAMA, 292(11): 1317–1325.
Yarbroff, K, Borowski, L and Lipsomb, J (2013) Economic studies in colorectal cancer: challenges in measuring and comparing costs. Journal of the National Cancer Institute Monograph, 2013(46): 62–78.